Drug Shortage Report for ACT AMLODIPINE
Report ID | 128034 |
Drug Identification Number | 02297493 |
Brand name | ACT AMLODIPINE |
Common or Proper name | AMLODIPINE 10MG TABLETS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | AMLODIPINE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-11-04 |
Estimated end date | 2021-01-31 |
Actual end date | 2021-01-20 |
Shortage status | Resolved |
Updated date | 2021-01-21 |
Company comments | |
Health Canada comments | |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.